Haemophilus is a group of bacteria that causes different types of illness such as breathing, bone and joint disorders and nervous system disorders. Among all the strains of Haemophilus, H infleunzae type b (Hib) is one of the most common types of infecton causing bacteria. The bacteria is also known as Bacillus Influenzae of Pfeiffer’s bacillus and it is a gram negative, facultatively, ccobacillary, anaerobic bacteria. This strain of bacterium belongs to the Pasteurellaceae family and was first isolated in 1892 during influenza pandemic. Some strains of the H. infleunzae posses a capsule of polysaccharide and on the basis of different biochemical properties of capsule these strains are classified into 6 different subtypes. Among all the strains of Haemophilus, H infleunzae type b (Hib) is the most virulent strain that is responsible for invasive infections. However, there are some strains of Haemophilus that have no capsule and can be termed as non encapsulated or nontypeable H.infleunzae. This strain of bacteria accounts for more than 95% of the infections occurring due to Haemophilus influenza in adults and children. H. infleunzae is also responsible for wide range of invasive and localized infections which can range from mild ear infection to other sever infections like blood stream infections. This strain can cause cellulitis, meningitis, epiglottis, urinary tract infections, septic arthritis, cervical adenitis, endocartis, osteomyelitis and glossitis. Infection caused by non encapsulated H.infleunzae strain includes sinusitis, pneumonia, bronchitis, otitis media and mucosal infections. 

Hib is a communicable disease and is spread through saliva or mucus. Most of the infections are found to communicate through sneezing or coughing. Thus, for the prevention of influenza infection, vaccination is one of the most common modes of treatment recommended. Thus, children under age of 5 are the most common victim for influenza who haven’t been vaccinated before. According to the WHO in 2000, Hib infections were responsible for cause of approximately 3 million cases of serious infections such as meningitis and pneumonia across the globe. Likewise, the infection also caused 386,000 deaths in young children worldwide. Thus, routine immunization against Haemophilus infection is used in over 100 countries. Additionally, diagnostic tests such as bacterial gram staining, blood cell counts, cerebrospinal fluid studies and others are the major laboratory testing studies performed. Similarly, computed tomography, chest radiography, echocardiography and lateral neck radiography are some of the imaging studies performed to confirm the infection. However, immunization or vaccination remains the major treatment for the prevention of Hib infections. Thus, most of the companies have their drug candidates in the pipeline and are expected to launch in the future. 

Rising incidences of Haemophilus Influenzae infection is one of the major causes for the growth of this market. In Japan every year more than 450 children, under the age of 5 years are affected by Hib meningitis. Similarly in the United States the overall incidence of Hib meningitis in children aged 0 years to 4 years 40 to 50 per 10,000. Thus, overall increasing incidences of Haemophilus influezae infection is luring many manufacturers to enter in this market. For, instance HibTITER a first conjugate vaccine proved to be successful in reducing the incidences of H.influenzae. Currently, Nuron Biotech has entered into partnership with Mitsubishi Corporation for the development of single antigen and conjugate vaccine against Hib infection for the Japanese market. 

Takeda Pharmaceuticals, GlaxoSmith Kline Plc, Sanofi, Inc., Novartis AG, Biological E. Limited, Panacea Biotech Limited, Zydus Cadila Healthcare Limited, Nuron Biotech, Inc., Sinovac Biotech Limited and others are some of the major players operating in this segment. 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Haemophilus Infections Market